BA
DGX icon

Boston Advisors’s Quest Diagnostics DGX Stock Holding History

Boston Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$3.68M Buy
34,392
+590
+2% +$60.6K 0.19% 136
2019
Q2 		$3.44M Sell
33,802
-7,843
-19% -$754K 0.18% 151
2019
Q1 		$3.75M Sell
41,645
-15,716
-27% -$1.36M 0.19% 150
2018
Q4 		$4.78M Sell
57,361
-748
-1% -$70.1K 0.28% 98
2018
Q3 		$6.27M Buy
58,109
+862
+2% +$94.5K 0.27% 108
2018
Q2 		$6.29M Buy
57,247
+175
+0.3% +$18.2K 0.16% 137
2018
Q1 		$5.72M Sell
57,072
-92,425
-62% -$9.47M 0.15% 150
2017
Q4 		$14.7M Sell
149,497
-31,135
-17% -$2.95M 0.32% 95
2017
Q3 		$16.9M Buy
180,632
+2,660
+1% +$282K 0.38% 77
2017
Q2 		$19.8M Buy
177,972
+54,488
+44% +$5.76M 0.46% 57
2017
Q1 		$12.1M Buy
123,484
+50,363
+69% +$4.8M 0.29% 118
2016
Q4 		$6.72M Buy
73,121
+1,565
+2% +$135K 0.16% 170
2016
Q3 		$6.06M Buy
71,556
+16,576
+30% +$1.39M 0.15% 165
2016
Q2 		$4.48M Buy
54,980
+2,063
+4% +$157K 0.11% 214
2016
Q1 		$3.78M Buy
52,917
+2,816
+6% +$189K 0.09% 219
2015
Q4 		$3.56M Buy
50,101
+34,567
+223% +$2.32M 0.08% 230
2015
Q3 		$955K Buy
+15,534
New +$1.09M 0.04% 384
2014
Q1 		– Sell
-14,309
Closed -$766K – 574
2013
Q4 		$766K Buy
14,309
+134
+0.9% +$7.95K 0.04% 297
2013
Q3 		$876K Sell
14,175
-800
-5% -$47.9K 0.05% 268
2013
Q2 		$908K Buy
+14,975
New +$892K 0.04% 254

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Boston Advisors's DGX Position: Q3 2019 in Review

Boston Advisors increased its Quest Diagnostics (DGX) stake by 1.7% in Q3 2019, buying an estimated $60.6K and bringing the position to 34,392 shares worth $3.68M. The position accounts for 0.19% of the portfolio, ranked #136.

Boston Advisors first reported a position in DGX in Q2 2013 and has held it in 20 quarters since. The position peaked at $19.8M in Q2 2017. 676 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

  • Boston Advisors held 34,392 shares of Quest Diagnostics worth $3.68M as of Q3 2019.
  • Boston Advisors bought 590 Quest Diagnostics shares in Q3 2019, an estimated $60.6K.
  • Quest Diagnostics made up 0.19% of Boston Advisors's portfolio in Q3 2019, its #136 holding.
  • Boston Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 20 quarters since.
  • Boston Advisors's Quest Diagnostics position peaked at $19.8M in Q2 2017.
  • 676 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.